Login
$IRLA
$32.96 +$0.48 (1.48%) Close

Insider Transactions

What IRulya Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 1
Total trades 0 5

Shares traded

3 months 12 months
Acquired 0 14,389
Disposed 0 14,810
Net activity +0 −421

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Luca Benatti Director Dec 26 Open-market sale · S −50,000 $3.47 −$174K 39,179
Thye Dirk CEO and CMO Dec 10 Gift · G +739,885 — — 739,885
Thye Dirk CEO and CMO Dec 10 Gift · G −739,885 — — 255,000
Hannah Brendan CBO, COO & CCO Dec 05 Exercise / conversion · M +25,280 $0.94 +$23.8K 361,827
Hannah Brendan CBO, COO & CCO Dec 05 Exercise / conversion · M +2,271 $0.55 +$1.25K 336,547
Hannah Brendan CBO, COO & CCO Jun 18 Grant / award · A +37,736 $1.20 +$45.3K 334,276
Ryan Charles S. President Jun 18 Grant / award · A +7,548 $1.20 +$9.06K 130,009
Thye Dirk CEO and CMO Jun 18 Grant / award · A +150,944 $1.20 +$181K 994,885
Luca Benatti Director Oct 23 Other Transaction · J +8,918 — — 89,179
Thye Dirk CEO AND CHIEF MEDICAL OFFICER Aug 30 Open-market buy · P +77,000 $0.70 +$53.9K 843,941
Thye Dirk CEO AND CHIEF MEDICAL OFFICER Aug 29 Open-market buy · P +77,500 $0.69 +$53.5K 766,941
Hannah Brendan CHIEF BUSINESS OFFICER AND COO Aug 21 Open-market buy · P +23,565 $0.63 +$14.8K 296,540
Hannah Brendan CHIEF BUSINESS OFFICER AND COO Aug 21 Open-market buy · P +5,000 $0.62 +$3.1K 272,975
Hannah Brendan CHIEF BUSINESS OFFICER AND COO Aug 21 Open-market buy · P +2,280 $0.61 +$1.39K 267,975
Hannah Brendan CHIEF BUSINESS OFFICER AND COO Aug 20 Open-market buy · P +3,424 $0.60 +$2.05K 265,695
Hannah Brendan CHIEF BUSINESS OFFICER AND COO Aug 20 Open-market buy · P +2,500 $0.61 +$1.53K 262,271
Ryan Charles S. PRESIDENT Aug 20 Open-market buy · P +48,387 $0.65 +$31.5K 122,461
Hannah Brendan CHIEF BUSINESS OFFICER AND COO Aug 19 Open-market buy · P +2,155 $0.58 +$1.25K 259,771
Hannah Brendan CHIEF BUSINESS OFFICER AND COO Jun 04 Exercise / conversion · M +56,061 $0.55 +$30.8K 257,616
Thye Dirk CHIEF EXECUTIVE OFFICER Jan 16 Exercise / conversion · M +149,999 $0.94 +$141K 689,441

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support